Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

Mercer also said 64% of U.S. employers with over 20,000 employees covered weight-loss drugs in 2024, compared with 56% last ...

In 2024, the percentage of U.S. employers covering weight-loss drugs has increased, with notable rises among larger employers ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

This investor's weighing up a couple of world-class companies for his Stocks and Shares ISA after the US election sparked a sell-off.